Hepatitis E Clinical Trial
Official title:
An Open, Pared Trial of Recombinant Hepatitis E Vaccine (Escherichia Coli) Hecolin® in the Chronic Hepatitis B Patients on the Clinical Stability .( Aged 30 Years or Over)
This phase IV clinical study was designed to evaluate the immunogenicity and safety of Hecolin® in the chronic Hepatitis B patients on the clinical stability.
This phase IV clinical study was designed to evaluate the immunogenicity and safety of the recombinant Hepatitis E vaccine(Hecolin®), manufactured by Xiamen Innovax Biotech CO., LTD., in the chronic Hepatitis B patients on the clinical stability and aged over 30 years of age at enrollment. The study volunteers will receive the 3 doses of Hecolin® administered intramuscularly according to a 0-1-6 month schedule. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT03365921 -
A Phase Ⅳ Clinical Trial of the Recombinant Hepatitis E Vaccine (Escherichia Coli)(the Lot Consistency Trial)
|
Phase 4 | |
| Completed |
NCT02584543 -
A Phase Ⅳ Clinical Trial of the Recombinant Hepatitis E Vaccine (Escherichia Coli)(Coadministration With Recombinant Hepatitis B Vaccine)
|
Phase 4 | |
| Not yet recruiting |
NCT03488589 -
HEV in Patients With Acute Non-A, Non-B, Non-C Hepatitis in Al-Rajhy University Hospital for Liver
|
||
| Completed |
NCT03601221 -
Seroprevalence Hepatitis E Infection in Healthy Blood Donors
|
||
| Completed |
NCT03168412 -
A Study on the Recombinant Hepatitis E Vaccine (Escherichia Coli) (Accelerated Vaccination Schedule)
|
Phase 4 | |
| Completed |
NCT02189603 -
Phase Ⅳ Clinical Trial of Recombinant Hepatitis E Vaccine（Hecolin®）
|
Phase 4 | |
| Completed |
NCT02847507 -
Seroprevalence of Hepatitis E in HIV Positive Patients in Basque Country in 2016 (VIhVhEpb)
|
||
| Completed |
NCT02603055 -
A Clinical Trial to Evaluate a Recombinant Hepatitis E Vaccine in Healthy Adults
|
Phase 1 | |
| Completed |
NCT02190253 -
Seroprevalence of Hepatitis E in People With an Organ Transplant
|
||
| Recruiting |
NCT06457438 -
Molecular Characteristics and Prevalence of Viral Hepatitis E in Human Tissue and Cell Donors
|
N/A | |
| Completed |
NCT04670419 -
Morbidity and Mortality of Hepatitis E Virus Infections in Belgium
|
||
| Completed |
NCT03282474 -
HepNet Pilot Trial: Multicenter Trial for the Treatment of Chronic Hepatitis E With Sofosbuvir (SofE)
|
Phase 2 | |
| Terminated |
NCT02558114 -
Ribavirin for Severe Acute and Chronic Hepatitis E Virus Infection.
|
Phase 4 | |
| Recruiting |
NCT06137313 -
Exposure to Hepatitis E Virus in Occitania, France
|
||
| Completed |
NCT01014845 -
Clinical Trial of Recombinant Hepatitis E Vaccine
|
Phase 3 | |
| Recruiting |
NCT05976594 -
Long-term Effectiveness of a Recombinant Hepatitis E Vaccine
|
||
| Completed |
NCT02417597 -
A Phase Ⅳ Clinical Trial of the Recombinant Hepatitis E Vaccine (Escherichia Coli)
|
Phase 4 | |
| Completed |
NCT03827395 -
Safety Study of Hepatitis E Vaccine (HEV239)
|
Phase 1 |